Daniel Virnich Transfers Shares of Oncology Institute Inc (TOI) — SEC Form 4, Mar 18, 2026

SEC Form 4 · No Market Transaction
Other Transaction

Non-market transaction reported.

Reporting Owner
TXN 2026-03-17 · FILED 2026-03-18
Equity Position 1.79M sh 1,799,984 → 1,788,150
Equity Change -0.7% shares held after vs before
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-03-18
Report Date
2026-03-18
Accession No.
0001079973-26-000332
Accepted At
2026-03-18 21:21 UTC
Reporting Owner
Name Relationship
Daniel Virnich CIK 0001891107
CEO
Daniel Virnich at Oncology Institute Inc Full insider history
Bought (12 mo) —
Sold (12 mo) —
More from this insider at Oncology Institute Inc
All filings by this insider at Oncology Institute Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2026-03-17 J - Other 11,834 D $3.59 -$42,484 1,788,150 Direct
Footnotes (1)
F1
The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 17, 2026. Show more
5%+ Holders · 13D/G 3 filers
Other insiders at Oncology Institute Inc
All Oncology Institute Inc insider activity
GET /v1/forms/4/0001079973-26-000332 API docs
View Original SEC Filing